Biochemical Journal

Error message

  • Notice: PHP Error: Undefined index: custom_texts in highwire_highwire_corrections_content_type_render() (line 33 of /opt/sites/jnl-ppbiochemj/drupal-highwire/releases/20151123210458/modules/highwire/plugins/content_types/
  • Notice: PHP Error: Undefined offset: 1 in nice_menus_block_view() (line 306 of /opt/sites/jnl-ppbiochemj/drupal-webroot/releases/20151123210521/sites/all/modules/contrib/nice_menus/nice_menus.module).
  • Notice: PHP Error: Undefined offset: 1 in nice_menus_block_view() (line 306 of /opt/sites/jnl-ppbiochemj/drupal-webroot/releases/20151123210521/sites/all/modules/contrib/nice_menus/nice_menus.module).

Accelerated Publication

Insulin-induced Drosophila S6 kinase activation requires phosphoinositide 3-kinase and protein kinase B

Jose M. LIZCANO, Saif ALRUBAIE, Agnieszka KIELOCH, Maria DEAK, Sally J. LEEVERS, Dario R. ALESSI


An important mechanism by which insulin regulates cell growth and protein synthesis is through activation of the p70 ribosomal S6 protein kinase (S6K). In mammalian cells, insulin-induced PI3K (phosphoinositide 3-kinase) activation, generates the lipid second messenger PtdIns(3,4,5)P3, which is thought to play a key role in triggering the activation of S6K. Although the major components of the insulin-signalling pathway are conserved in Drosophila, recent studies suggested that S6K activation does not require PI3K in this system. To investigate further the role of dPI3K (Drosophila PI3K) in dS6K (Drosophila S6K) activation, we examined the effect of two structurally distinct PI3K inhibitors on insulin-induced dS6K activation in Kc167 and S2 Drosophila cell lines. We found that both inhibitors prevented insulin-stimulated phosphorylation and activation of dS6K. To investigate further the role of the dPI3K pathway in regulating dS6K activation, we also used dsRNAi (double-stranded RNA-mediated interference) to decrease expression of dPI3K and the PtdIns(3,4,5)P3 phosphatase dPTEN (Drosophila phosphatase and tensin homologue deleted on chromosome 10) in Kc167 and S2 cells. Knock-down of dPI3K prevented dS6K activation, whereas knock-down of dPTEN, which would be expected to increase PtdIns(3,4,5)P3 levels, stimulated dS6K activity. Moreover, when the expression of the dPI3K target, dPKB (Drosophila protein kinase B), was decreased to undetectable levels, we found that insulin could no longer trigger dS6K activation. This observation provides the first direct demonstration that dPKB is required for insulin-stimulated dS6K activation. We also present evidence that the amino-acid-induced activation of dS6K in the absence of insulin, thought to be mediated by dTOR (Drosophila target of rapamycin), which is unaffected by the inhibition of dPI3K by wortmannin. The results of the present study support the view that, in Drosophila cells, dPI3K and dPKB, as well dTOR, are required for the activation of dS6K by insulin.

  • Drosophila
  • insulin signalling
  • phosphatase and tensin homologue deleted on chromosome 10 (PTEN)
  • phosphoinositide 3-kinase (PI3K)
  • protein kinase B (PKB)
  • S6 kinase (S6K)


  • Abbreviations used: d, Drosophila; dsRNAi, double-stranded RNA-mediated interference; MAPK, mitogen-activated protein kinase; mTOR, mammalian target of rapamycin; PDK1, 3-phosphoinositide-dependent protein kinase-1; PI3K, phosphoinositide 3-kinase; PKB, protein kinase B; PTEN, phosphatase and tensin homologue deleted on chromosome 10; S6K, p70 ribosomal S6 kinase; TOR, target of rapamycin; TSC, tuberous sclerosis complex.